NCT02669368

Magnesium Sulfate Effects on Onset and Duration of Low Dose Rocuronium in Patients Undergoing Laparoscopic Cholecystectomy

Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium in Patients Undergoing Laparoscopic Cholecystectomy

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 75 (estimated)
• Sponsor: Assiut University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study aims to evaluate effects of magnesium sulfate on onset and duration of low dose rocuronium, intubation condition and surgical condition in patients undergoing laparoscopic cholecystectomy.

Conditions

• Muscle Relaxation

Interventions

Type	Name	Description
DRUG	Magnesium Sulfate	Patients in each group receive Magnesium sulfate 30 mg/kg in 0.9% normal saline (total volume 100 ml) intravenously for 5 min before induction of anesthesia
DRUG	Saline	Patients in each group receive 0.9% normal saline (total volume 100 ml) alone intravenously for 5 min before induction of anesthesia
DRUG	Standard dose Rocuronium	0.6 mg/kg of Rocuronium given with induction of anesthesia
DRUG	Low dose Rocuronium	0.45 mg/kg of Rocuronium given with induction of anesthesia

Timeline

• Start date: 2015-03-01
• Primary completion: 2016-03-01
• First posted: 2016-02-01
• Last updated: 2016-02-01

Locations

1 site across 1 country: Egypt